Delo criticises state's inability to fund life-saving drugs registered only in US
Ljubljana, 27 September - The newspaper Delo wonders in its front-page commentary on Friday whether charity was the only way to help patients who require life-saving treatments that have not yet been registered in the EU. It is critical of the state for failing to help, while being willing to throw millions at banks and companies, often without the desired effect.
The rest of this news item is available to subscribers.
The news item consists of 1.188 characters (without spaces) or 257 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.